T32 Pediatric Clinical and Developmental Pharmacology Training Network (PCDPTN)
The purpose of the BPCA-funded T32 PCDPTN institutional research training grant program is to help ensure that a diverse and highly trained workforce is available in an area that currently has a limited number of researchers. Without an increase in the pool of investigators trained in new "-omics" technologies and their application to pediatric therapeutics, integration and synergistic interaction will not be possible, and the overall goal of personalized pediatric therapeutics will not be realized.
This collaborative network—which allows interdisciplinary collaboration of clinical, translational, and basic investigators who research pediatric therapeutics—is mandated through the BPCA legislation.
PCDPTN History and Collaborations
PCDPTN formed in 2011 when the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Institute of General Medical Sciences (NIGMS) co-funded six pediatric positions under NIGMS’ T32 Postdoctoral Programs in Clinical Pharmacology.
NICHD then supplemented these sites by adding five new programs through their own Postdoctoral Research Training in Pediatric Clinical and Developmental Pharmacology T32 training grants.
In 2017, an existing training site added a new position in collaboration with the National Institute of Mental Health (NIMH). This new position was created to address the need for pharmacology training of psychiatric subspecialists. Additional fellowships are expected to follow in the coming terms.
Since the program’s inception, more than 70 participants have graduated from the NICHD, NICHD-NIGMS, and NICHD-NIMH T32 training programs.
Goals of the PCDPTN are to:
- Provide training in pediatric clinical pharmacology
- Stimulate interdisciplinary collaboration among clinical, translational, and basic researchers in pediatric therapeutics
- Enable the development of a pediatric pharmacology section within the adult clinical pharmacology department
PCDPTN’s activities include harmonization of fellows’ core curriculum, development of strategies to bridge the gap between adult and pediatric therapeutics, a journal club, and coordination of a weekly lecture series about topics of relevance to pediatric pharmacology.
An Annual Meeting provides an opportunity for fellows to meet other trainees in the program, learn about research at other institutions, and hear presentations by experts in the field and fellow trainees.